Legend Biotech
LEGN
LEGN
192 hedge funds and large institutions have $5.81B invested in Legend Biotech in 2023 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 59 increasing their positions, 65 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
22% more funds holding
Funds holding: 158 → 192 (+34)
5.21% more ownership
Funds ownership: 20.32% → 25.53% (+5.2%)
9% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 65
Holders
192
Holding in Top 10
9
Calls
$31.7M
Puts
$13.3M
Top Buyers
| 1 | +$548M | |
| 2 | +$264M | |
| 3 | +$90.2M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$67.1M |
| 5 |
Holocene Advisors
New York
|
+$62.6M |
Top Sellers
| 1 | -$56.2M | |
| 2 | -$33.6M | |
| 3 | -$27.4M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$24.1M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$22.2M |